Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.
We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients.
To strengthen our Safety Evidence and Insights team, we are seeking an experienced pharmaceutical professional who can connect medical science, safety evidence and business strategy across the product lifecycle.
The Safety Evidence (Medical) Lead will generate and translate safety evidence into insights that differentiate argenx therapies, strengthen understanding of their benefit-risk profile, and inform evidence and product strategy. The role combines medical/scientific expertise, data analytics and strategic thinking, integrating evidence from internal safety data, real-world data, post-authorization studies, medical literature and other relevant sources.
This role does not simply generate safety evidence. It identifies where safety evidence can create meaningful scientific and strategic differentiation, then builds the evidence needed to realize that opportunity.
The successful candidate will operate as both a strategic thought partner and hands-on evidence leader, bringing deep understanding of drug development, safety science and the broader competitive environment.
We are looking for candidates based in Belgium, Switzerland or US (EST time zone.
The Safety Evidence (Medical) Lead will:
Strategic Safety Intelligence & Differentiation
Evidence Strategy & Generation
Scientific Leadership & Influence
Candidates must be based in Belgium, Switzerland or US (EST time zone) to be considered for this role.
At argenx, all applicants are welcomed in an inclusive environment. They will receive equal consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other applicable legally protected characteristics. argenx is proud to be an equal opportunity employer.
Before you submit your application, CV or any other personal details to us, please review our argenx Privacy Notice for Job Applicants to learn more about how argenx B.V. and its affiliates (“argenx”) will handle and protect your personal data. If you have any questions or you wish to exercise your privacy rights, please contact our Global Privacy Office by email at privacy@argenx.com.

argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines.